Black Women More Likely To Have Vitamin D Deficiency, Bacterial Vaginosis, Study Finds

May 31, 2009 by admin · Leave a Comment 

Black women are nearly three times as likely as white women to have a vitamin D deficiency, which is linked with an increased risk of the vaginal infection bacterial vaginosis, according to a study published in the June issue of the Journal of Nutrition, the New York Times reports.

Source: Black Women More Likely To Have Vitamin D Deficiency, Bacterial Vaginosis, Study Finds

Thailand Aims To Halve New HIV Cases By 2011, Prime Minister Says

May 31, 2009 by admin · Leave a Comment 

Thailand has set a goal of reducing by half the number of new HIV cases in the country by 2011, Prime Minister Abhisit Vejjajiva said on Wednesday, TNA/MCOT English News reports.

Source: Thailand Aims To Halve New HIV Cases By 2011, Prime Minister Says

Tadalafil (Cialis) In The Treatment Of Erectile Dysfunction

May 31, 2009 by admin · Leave a Comment 

UroToday.com – This updated review of tadalafil (Cialis), one of the three available phosphodiesterase type 5 (PDE5) inhibitors that revolutionized the treatment of erectile dysfunction (ED), analyzes its latest clinical studies. Tadalafil’s most unique and identifying characteristic is its long half-life of 17.5 hours, compared with 4 hours for sildenafil (Viagra) and vardenafil (Levitra).

Source: Tadalafil (Cialis) In The Treatment Of Erectile Dysfunction

New HIV Microbicide Developed– And A Way To Mass Produce It In Plants

May 31, 2009 by admin · Leave a Comment 

In what could be a major pharmaceutical breakthrough, research published online in The FASEB Journal describes how scientists from St George’s, University of London have devised a one-two punch to stop HIV. First the report describes a new protein that can kill the virus when used as a microbicide. Then the report shows how it might be possible to manufacture this protein in quantities large enough to make it affordable for people in developing countries.

Source: New HIV Microbicide Developed– And A Way To Mass Produce It In Plants

HRA Pharma Granted European Marketing Authorization For EllaOne(R) – Next Generation Emergency Contraceptive

May 30, 2009 by admin · Leave a Comment 

HRA Pharma, a privately-held, European pharmaceutical company that designs products, devices and supporting services in reproductive health and endocrinology, announced today that ellaOne(R) (ulipristal acetate), its next generation emergency contraceptive, has been granted marketing authorization by the European Commission.

Source: HRA Pharma Granted European Marketing Authorization For EllaOne(R) – Next Generation Emergency Contraceptive

Next Page »